PDF
The global overactive bladder treatment market is estimated to grow at a CAGR of nearly 3.5% during the forecast period. Rising FDA approvals for new drugs and devices to treat overactive bladder is offering an opportunity for market growth. With the growing incidences of urinary incontinence, spinal cord injuries, and Parkinsonu2019s disease, the pharmaceutical and medical device manufacturers are working towards the development of new therapies for the treatment of these conditions.